Efficacy and safety of abacavir/lamivudine plus rilpivirine as a first-line regimen in treatment-naïve HIV-1 infected adults

Efficacy and safety of abacavir/lamivudine plus rilpivirine as a first-line regimen in treatment-naïve HIV-1 infected adults

10.1186/s12981-020-00272-5

Saved in:
Bibliographic Details
Main Authors: Ho, S., Wong, J.G., Ng, O.T., Lee, C.C., Leo, Y.S., Lye, D.C.B., Wong, C.S.
Other Authors: MEDICINE
Format: Article
Published: BioMed Central Ltd. 2021
Subjects:
Abacavir
Antiretroviral
HIV
Rilpivirine
Treatment-naïve
Online Access:https://scholarbank.nus.edu.sg/handle/10635/196593
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore

Internet

https://scholarbank.nus.edu.sg/handle/10635/196593

Similar Items